Table 1.

Characteristics of the patients with recurrent mucinous ovarian cancer compared to other histological subtypes at the time of initial diagnosis of ovarian cancer.

	Mucinous	Other histotypes	p
Number of patients	20	388
Age (years)	20	384	n.s.*
Mean (± s.d.)	54.9 ± 12.5	57.7 ± 10.8
median	55	57
range	25–71	31–94
FIGO stage at diagnosis	20	383
I	20.0%	6.5%	0.0258**
II	10.0%	7.3%
III	65.0%	77.0%
IV	5.0%	9.1%
Grading	12	348
1	25.0%	3.4%	0.0056**
2	16.7%	24.7%
3	58.3%	71.8%
Result of cytoreductive surgery	15	319
No residual disease	46.7%	26.0%	n.s.**
Optimal (≤ 1 cm residual disease)	20.0%	29.5%
Suboptimal (> 1 cm residual disease)	33.3%	44.5%
ECOG performance status	15	347
0	60.0%	68.3%	n.s.**
1	33.3%	26.5%
2	6.7%	4.3%
3	.	0.9%
Type of first line chemotherapy	20	338	n.s.***
Platinum single agent	15.0%	11.1%
Platinum based combinations	85.0%	88.9%

• t-test; ** χ² Mantel-Haenszel; *** χ²